Search

Displaying results 1571 - 1580 of 10000 in total
  1. Target

    Calcium-dependent secretion activator 1

    go.drugbank.com/bio_entities/BE0008704
    TargetHumans

    Calcium-binding protein involved in exocytosis of vesicles filled with neurotransmitters and neuropeptides. … Probably acts upstream of fusion in the biogenesis or maintenance of mature secretory vesicles. Regulates catecholamine loading of DCVs.

    Synonyms: Calcium-dependent activator protein for secretion 1
  2. Indication

    Cognitive Impairment (CI)

    go.drugbank.com/conditions/DBCOND0138824
    Drugs: Piracetam
    Synonyms: Disturbance in cognition
  3. Drug

    Clopidogrel

    go.drugbank.com/drugs/DB00758
    ApprovedInvestigational

    in recent MI, stroke, or established peripheral arterial disease,[L7213] It has been shown to be superior to [aspirin] in reducing cardiovascular outcomes in patients with cardiovascular disease and … [A180508,L7213] Clopidogrel is indicated to reduce the risk of myocardial infarction for patients with non-ST elevated acute coronary syndrome (ACS), patients with ST-elevated myocardial infarction, and

    Mixtures: CO-DEGREGANProducts: Rbx-clopidogrel
  4. Drug

    Copper

    go.drugbank.com/drugs/DB09130
    ApprovedInvestigational

    Copper is a transition metal and a trace element in the body. It is important to the function of many enzymes including cytochrome c oxidase, monoamine oxidase and superoxide dismutase [FDA Label]. … Copper is commonly used in contraceptive intrauterine devices (IUD) [L801].

    Mixtures: For-2, vitaMedMD Rx Plus
  5. Drug

    Etrasimod

    go.drugbank.com/drugs/DB14766
    ApprovedInvestigational

    [A261831] Etrasimod was approved on October 13, 2023, by the FDA under the brand name VELSIPITY for the treatment of adults with moderately to severely active ulcerative colitis. … Etrasimod is a synthetic next-generation selective Sphingosine 1-phosphate (S1P) receptor modulator that targets the S1P<sub>1,4,5</sub> with no detectable activity on S1P<sub>2</sub> and S1P<sub>3</sub

  6. Indication

    Relapsed Acute Myelogenous Leukemia (AML)

    go.drugbank.com/conditions/DBCOND0069493
    Drugs: Enasidenib · Gemtuzumab ozogamicin · Ivosidenib · Olutasidenib · Revumenib · Ziftomenib
    Synonyms: Acute Myelogenous Leukemia in Relapse
  7. Drug

    (R)-carnitinyl-CoA betaine

    go.drugbank.com/drugs/DB02516
    Experimental

    Synonyms: R-carnitinyl-CoA inner salt, (R)-carnitinyl-CoA βine
  8. Drug

    Valsartan

    go.drugbank.com/drugs/DB00177
    ApprovedInvestigational

    [A174124,A173869] Valsartan was initially approved in 1996 in Europe for the treatment of hypertension in adults. Shortly after, in 1997, this drug was approved in the United States. … Valsartan is commonly used for the management of hypertension, heart failure, and Type 2 Diabetes-associated nephropathy, particularly in patients who are unable to tolerate ACE inhibitors.

    Mixtures: CARDIK - IN® 160/2.5, CARDIK - IN® 160/2.5Categories: Antihypertensive Agents Indicated for Hypertension, Agents Acting on the Renin-Angiotensin System
  9. Drug

    Dipropylene glycol

    go.drugbank.com/drugs/DB14140
    Investigational

    Products: Abelia pomegranate bounce up mask
  10. Indication

    Sleeping Disorders

    go.drugbank.com/conditions/DBCOND0148601
    Drugs: Amitriptyline · Cinolazepam · Delorazepam · Lormetazepam · Melperone · Mirtazapine +2 more
    Synonyms: Disturbance in sleep behavior, NOS, Disturbance in sleep behavior (finding)